Never underestimate the power of a brisk walk. The CDC recommends taking a stroll for 30 minutes a day, five days a week. The ...

When you can't fit a workout into every day, an expert MD in obesity medicine lists the most impactful ways to lose weight ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...

Forbes contributors publish independent expert analyses and insights. Across the earlier articles in this series, we developed a framework for understanding why weight loss and regulation is far more ...

When used with the appropriate medical guidance, GLP-1 medications like Ozempic, Wegovy and Mounjaro can be an effective route to sustainable weight loss. One such route is, of course, through the NHS ...

Fat-burning workouts don’t have to end in a puddle of sweat and tears. There are all kinds of ways to lose weight with exercise. Heck, you can even walk it off. In fact, if you’re at the beginning of ...

Weight loss can change a person's life and boost health, especially after years of struggling with obesity. No wonder losing weight is among the top 2026 New Year’s resolutions for Americans, along ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

The best weight loss supplements for women may include magnesium, caffeine, green tea, protein, fiber, and vitamin B12. The FDA doesn’t closely regulate supplements, so they’re not guaranteed to be ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...